Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

BridgeBio Pharma (BBIO) Shares Repurchased: 2020-2025

Historic Shares Repurchased for BridgeBio Pharma (BBIO) over the last 1 years, with Mar 2025 value amounting to $48.3 million.

  • BridgeBio Pharma's Shares Repurchased was N/A to $48.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $198.3 million, marking a year-over-year change of. This contributed to the annual value of $200.0 million for FY2021, which is 166.67% up from last year.
  • Per BridgeBio Pharma's latest filing, its Shares Repurchased stood at $48.3 million for Q1 2025, which was up 3,030.74% from $1.5 million recorded in Q4 2021.
  • Over the past 5 years, BridgeBio Pharma's Shares Repurchased peaked at $143.2 million during Q3 2021, and registered a low of $1.5 million during Q4 2021.
  • Its 1-year average for Shares Repurchased is $48.3 million, with a median of $48.3 million in 2025.
  • Data for BridgeBio Pharma's Shares Repurchased shows a maximum YoY tumbled of 33.33% (in 2021) over the last 5 years.
  • Over the past 2 years, BridgeBio Pharma's Shares Repurchased (Quarterly) stood at $1.5 million in 2021, then followed by $48.3 million in 2025.
  • Its Shares Repurchased was $48.3 million in Q1 2025, compared to $1.5 million in Q4 2021 and $143.2 million in Q3 2021.